We look forward to working with partners to apply our novel platform to develop more efficacious and safe cell therapies. Please reach out to us to discuss partnering opportunities and how together we can build better cell therapies for patients in need across oncology indications (CAR-T, CAR-NK, TCR-T, TILs, etc), autoimmune indications, and other cell therapy applications (diabetes, etc).